Diploma PLC (LON:DPLM - Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 4,270.70 ($57.46) and traded as high as GBX 4,762 ($64.07). Diploma shares last traded at GBX 4,692 ($63.13), with a volume of 362,174 shares changing hands.
Diploma Price Performance
The company has a market cap of £6.25 billion, a price-to-earnings ratio of 53.86, a PEG ratio of 2.82 and a beta of 0.75. The company's fifty day moving average price is GBX 4,072.26 and its two-hundred day moving average price is GBX 4,269.68. The company has a quick ratio of 0.80, a current ratio of 2.17 and a debt-to-equity ratio of 62.17.
Diploma (LON:DPLM - Get Free Report) last posted its earnings results on Wednesday, May 21st. The company reported GBX 80.20 ($1.08) EPS for the quarter. Diploma had a return on equity of 13.18% and a net margin of 9.25%. On average, equities research analysts forecast that Diploma PLC will post 163.7995512 EPS for the current fiscal year.
Insider Buying and Selling
In other news, insider Ian El-Mokadem purchased 500 shares of the firm's stock in a transaction dated Monday, March 24th. The shares were purchased at an average price of GBX 3,948 ($53.12) per share, with a total value of £19,740 ($26,560.82). Also, insider David S. Lowden purchased 750 shares of the business's stock in a transaction on Friday, March 21st. The shares were acquired at an average price of GBX 3,928 ($52.85) per share, with a total value of £29,460 ($39,639.40). Insiders purchased a total of 1,346 shares of company stock valued at $5,393,173 in the last three months. Insiders own 0.52% of the company's stock.
About Diploma
(
Get Free Report)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Featured Stories
Before you consider Diploma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.
While Diploma currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
